IceCure Medical Ltd.

Biotechnology · CAESAREA, L3

BiotechnologySEC Form D

IceCure Medical Ltd. filed a Form D with the U.S. Securities and Exchange Commission on March 31, 2026, reporting $4,000,000 raised.

Incorporated in Israel and based in CAESAREA, L3, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that IceCure Medical Ltd. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Eyal ShamirExecutive Officer · Director
  • Ronen TsimermanExecutive Officer
  • Ron MayronDirector
  • Shay LevavExecutive Officer
  • Naum MuchnikExecutive Officer
  • Tlalit Bussi Tel-TzureExecutive Officer
  • Merav Nir DotanExecutive Officer
  • Shad GoodExecutive Officer
  • Vincent Chun Hung ChanDirector
  • Yang HuangDirector
  • Sharon LevitaDirector
  • Yonatan MalcaDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$10.0MRaised

Senti Biosciences Holdings, Inc.

BiotechnologySouth San Francisco, CA
May 20, 2026View SEC Form D
IceCure Medical Ltd. raised $4.0M — SEC Form D